RxDoctor Payments Data

Brack Hattler

Cardiovascular Disease · Aurora, CONPI 1376511923

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $818 of the $1,166 with a category attached, or 70.1%. Amgen accounts for 94.1% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2019 at $1,097 and has fallen 97.9% since, to $23 in 2025. That places this record below the midpoint for cardiovascular disease clinicians in CO, where the typical reported total is $1,537.

$1,166in general payments, 2019–2025

Across 13 payments — averaging $89.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$1K
  • Abbott$46
  • Boston Scientific$23
$788,762in research payments, 2019–2025

Across 204 payments — averaging $3866.48 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Livanova USA, Inc.$204K
  • Abbott$110K
  • Bayer$103K
  • Amgen$89K
  • Novartis$83K
  • AstraZeneca$51K
  • plus $149K from 4 others

What the payments were for

  • Travel & lodging$81870%
  • Food & beverage$34830%

General payments by program year

19
20
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Amgen10$1,097
Abbott2$46
Boston Scientific1$23

How this compares

$1,166 in reported general payments places this provider in the 45th percentile of 276 cardiovascular disease providers in Colorado.

See all cardiovascular disease providers in Colorado →

Other cardiovascular disease in Aurora

See the full list for Colorado →

Where these figures come from

Is this you, or does something look wrong? →